Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Biomarker Predicts Taxane-Induced Neuropathy

May 23, 2011 7:13 am | News | Comments

Researchers at Indiana University identified a genetic biomarker that causes neuropathy among breast cancer patients using taxanes.

TOPICS:

Motorized Microscope Stage

May 23, 2011 5:40 am | Product Releases | Comments

Prior Scientific’s H117P2NN flat top stage for the Nikon Ti series of inverted microscopes,  can assist researchers conducting prolonged live cell studies.

TOPICS:

Atomic-level Spectroscopy

May 23, 2011 5:31 am | Product Releases | Comments

FEI has extended its ChemiSTE Technology to enableatomic-level energy dispersive X-ray (EDX) spectroscopy across the periodic table.

TOPICS:
Advertisement

Shire Receives Notice Letter from Sandoz

May 20, 2011 11:56 am | News | Comments

Shire LLC has received a Paragraph IV Notice Letter from Sandoz Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of all strengths of VYVANSE.

TOPICS:

Logos and Medidata Partner

May 20, 2011 11:51 am | News | Comments

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, announced London-based Logos Technologies as a Medidata Technology Partner.

TOPICS:

Stem Cell PCR Kit

May 20, 2011 11:47 am | Product Releases | Comments

AMSBIO has announced the launch of the PluriPCR Kit, a new benchmark to revolutionize the definition of stem cell pluripotency. The PluriPCR kit has been designed as a quantitative and reliable assay of five genes strongly specific to pluripotency.

TOPICS:

Roller Bottle

May 20, 2011 11:41 am | Drug Discovery & Development | Product Releases | Comments

Greiner Bio-One North America, Inc. now offer the Cellmaster Roller Bottle product portfolio, designed to fulfill different requirements for the production of virus vaccines or recombinant proteins used for therapeutic approaches.

TOPICS:

Regulators OK Extended Patient Treatment

May 20, 2011 11:34 am | News | Comments

TxCell SA announces the approval by AFSSAPS, the French regulatory agency, of its application to extend treatment of patients included in the Crohn’s Disease phase 1/2 study with Ovasave, a type 1 regulatory T cell based immunotherapy.

TOPICS:
Advertisement

TM-400 Granted Orphan Drug Status

May 20, 2011 11:28 am | News | Comments

TikoMed AB announced that TM-400 has been granted orphan drug designation for treatment to mobilize progenitor cells prior to stem cell transplantation by the European Medicines Agency.

TOPICS:

Pfizer's Eliquis Approved in Europe

May 20, 2011 11:24 am | News | Comments

Drugmaker Pfizer said that European regulators have approved its highly-anticipated blood thinner Eliquis to prevent blood clots in patients who have had hip or knee replacement surgery.

TOPICS:

EMA Panel Recommends Victrelis Approval

May 20, 2011 11:21 am | News | Comments

Drugmaker Merck & Co. said that a European drug agency has endorsed its hepatitis C treatment Victrelis, also known as boceprevir - a key step toward possible approval in the European Union.

TOPICS:

FDA Approves New HIV Drug

May 20, 2011 11:19 am | News | Comments

The Food and Drug Administration said it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus.

TOPICS:

Pearl Therapeutics Study Shows Lung Function Improvement

May 20, 2011 6:21 am | News | Comments

Pearl Therapeutics Inc. presented efficacy and safety results in the company's Phase 2b study of PT003 (GFF MDI) in patients with moderate-to-very severe COPD at the annual meeting of the American Thoracic Society (ATS).

TOPICS:

Safety Committee Reports Findings on Gardasil

May 20, 2011 6:16 am | News | Comments

An independent safety review committee reported study findings on nearly 190,000 females who received at least one dose of Merck’s Gardasil, a quadrivalent human papillomavirus vaccine (qHPV) at two managed care associations between August 2006 and March 2008.

TOPICS:

Eli Lilly Names Senior Medical Advisor

May 20, 2011 6:12 am | News | Comments

David M. Kendall, MD, currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading